X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE WOCKHARDT LTD. TTK HEALTHCARE/
WOCKHARDT LTD.
 
P/E (TTM) x 32.9 -18.4 - View Chart
P/BV x 6.1 3.0 201.4% View Chart
Dividend Yield % 0.5 1.1 43.8%  

Financials

 TTK HEALTHCARE   WOCKHARDT LTD.
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
WOCKHARDT LTD.
Mar-17
TTK HEALTHCARE/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs6631,129 58.8%   
Low Rs399627 63.6%   
Sales per share (Unadj.) Rs535.6363.1 147.5%  
Earnings per share (Unadj.) Rs15.9-20.4 -78.0%  
Cash flow per share (Unadj.) Rs20.0-7.0 -287.1%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %0.81.1 66.1%  
Book value per share (Unadj.) Rs137.6301.8 45.6%  
Shares outstanding (eoy) m7.77110.55 7.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.02.4 41.0%   
Avg P/E ratio x33.3-42.9 -77.6%  
P/CF ratio (eoy) x26.5-125.9 -21.1%  
Price / Book Value ratio x3.92.9 132.7%  
Dividend payout %25.1-48.9 -51.3%   
Avg Mkt Cap Rs m4,12797,063 4.3%   
No. of employees `0001.76.8 25.2%   
Total wages/salary Rs m6079,665 6.3%   
Avg. sales/employee Rs Th2,436.75,931.8 41.1%   
Avg. wages/employee Rs Th355.21,428.1 24.9%   
Avg. net profit/employee Rs Th72.5-334.0 -21.7%   
INCOME DATA
Net Sales Rs m4,16240,146 10.4%  
Other income Rs m611,143 5.4%   
Total revenues Rs m4,22341,289 10.2%   
Gross profit Rs m197128 154.0%  
Depreciation Rs m321,489 2.1%   
Interest Rs m302,253 1.3%   
Profit before tax Rs m197-2,472 -8.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-211 -34.5%   
Profit after tax Rs m124-2,260 -5.5%  
Gross profit margin %4.70.3 1,485.4%  
Effective tax rate %37.08.5 433.3%   
Net profit margin %3.0-5.6 -52.9%  
BALANCE SHEET DATA
Current assets Rs m1,62946,160 3.5%   
Current liabilities Rs m1,05819,258 5.5%   
Net working cap to sales %13.767.0 20.5%  
Current ratio x1.52.4 64.2%  
Inventory Days Days30101 29.6%  
Debtors Days Days3494 35.7%  
Net fixed assets Rs m55640,165 1.4%   
Share capital Rs m78553 14.1%   
"Free" reserves Rs m87832,814 2.7%   
Net worth Rs m1,06933,367 3.2%   
Long term debt Rs m15931,903 0.5%   
Total assets Rs m2,39989,687 2.7%  
Interest coverage x7.6-0.1 -7,802.7%   
Debt to equity ratio x0.11.0 15.5%  
Sales to assets ratio x1.70.4 387.5%   
Return on assets %6.40 -74,660.7%  
Return on equity %11.6-6.8 -171.0%  
Return on capital %18.5-0.3 -5,504.6%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m339,121 0.4%   
Fx outflow Rs m632,133 3.0%   
Net fx Rs m-306,988 -0.4%   
CASH FLOW
From Operations Rs m127-2,695 -4.7%  
From Investments Rs m-146-6,863 2.1%  
From Financial Activity Rs m2212,545 0.2%  
Net Cashflow Rs m33,010 0.1%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 2.3 160.9%  
FIIs % 5.2 7.7 67.5%  
ADR/GDR % 0.0 0.1 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 67,757 18.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DIVIS LABORATORIES  GLENMARK PHARMA  SUN PHARMA  PLETHICO PHARMA  FDC LTD.  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 18, 2018 03:35 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS